New drug shows promise in treating liver disease caused by metabolic dysfunction, cancer
Contact: Eileen Teves, 210-450-7239, [email protected] Content provided by Claire Kowalick SAN ANTONIO, March 5, 2025 – A study published in Nature...
liver
Metabolic outcomes in non-alcoholic and alcoholic steatotic liver disease among Korean and American adults | BMC Gastroenterology
Baseline characteristics of the participantsThe general characteristics of the participants in the KNHANES, NHANES, and KoGES cohorts according to steatotic...
China’s liver health supplement market led by detox, skin brightening needs
This is according to a new report published by e-commerce firm JD and Nielsen. Titled “2024 White Paper on China Cross-Border...
MASH: Understanding metabolic disease associated steatohepatitis and its impact on liver health
Nonalcoholic Steatohepatitis (NASH) is a liver condition that is increasingly common worldwide and poses a significant health risk. It is...
